October 7 - 11, 2019
Porto Bay Falésia Hotel
Deadline expired on May 31, 2019
Cancer Core Europe (CCE)
Cancer Core Europe brings together the Cambridge Cancer Centre, the German Cancer Research Center and its National Center for Tumor Diseases (Heidelberg, Germany), the Gustave Roussy Cancer Campus Grand Paris (Villejuif, France), the National Tumor Institute of Milan (Milan, Italy), the Karolinska Institutet (Stockholm, Sweden), the Netherlands Cancer Institute (Amsterdam, The Netherlands), and the Vall d’Hebron Institute of Oncology (Barcelona, Spain). Given the excellent track records of the seven participants, Cancer Core Europe will be able to support the full spectrum of research required to address the cancer research – cancer care continuum. Cancer Core Europe also constitutes a unique environment for the training of up-and-coming talents in innovative translational and clinical oncology.
German Cancer Research Center (DKFZ)
The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) with its more than 3,000 employees is the largest biomedical research institute in Germany. At DKFZ, more than 1,000 scientists investigate how cancer develops, identify cancer risk factors and endeavor to find new strategies to prevent people from getting cancer. They develop novel approaches to make tumor diagnosis more precise and treatment of cancer patients more successful. The staff of the Cancer Information Service (KID) offers information about the widespread disease of cancer for patients, their families, and the general public. Jointly with Heidelberg University Hospital, DKFZ has established the National Center for Tumor Diseases (NCT) Heidelberg, where promising approaches from cancer research are translated into the clinic. In the German Consortium for Translational Cancer Research (DKTK), one of six German Centers for Health Research, DKFZ maintains translational centers at seven university partnering sites. Combining excellent university hospitals with high-profile research at a Helmholtz Center is an important contribution to improving the chances of cancer patients. DKFZ is a member of the Helmholtz Association of National Research Centers, with ninety percent of its funding coming from the German Federal Ministry of Education and Research and the remaining ten percent from the State of Baden-Württemberg.
National Center for Tumor Diseases (NCT) Heidelberg
The NCT Heidelberg is supported by the German Cancer Research Center (DKFZ), the University Hospital of Heidelberg in cooperation with the Medical Faculty Heidelberg and by the German Cancer Aid (Deutsche Krebshilfe). The latter promotes the NCT as an Oncological centre of excellence in Heidelberg. Inspired by American and Scandinavian models, the NCT is a modern oncology center (“Comprehensive Cancer Center”) which has been adapted to the German health care system. One of the outstanding characteristics of the NCT is its comprehensive and interdisciplinary approach, providing all relevant aspects for a successful fight against cancer.
German Cancer Consortium (DKTK)
The German Cancer Consortium (DKTK) is a joint long-term initiative involving the German Federal Ministry of Education and Research (BMBF), participating German states, German Cancer Aid and the German Cancer Research Center (DKFZ) and was established as one of six German Health Research Centres (DZGs). The German Cancer Research Center works together with research institutions and hospitals in Berlin, Dresden, Essen/Düsseldorf, Frankfurt/Mainz, Freiburg, Heidelberg, Munich and Tübingen to create the best possible conditions for clinical cancer research. The consortium promotes interdisciplinary research at the interface between basic research and clinical research, as well as clinical trials for innovative treatments and diagnostic methods. Another key focus of the consortium’s work is on developing research platforms to speed up the application of personalized cancer treatments and to improve the diagnosis and prevention of cancer.